title: [Lack of uniformity in the treatment of thymomas].
abstract: Thymomas are the most frequently occurring tumours of the anterior mediastinum. However, they only constitue less than 1% of the total number of malignant diseases.  The incidence in the USA is 0.15 per 100.000 persons per year, and the disease is most frequent in persons between 40 and 60 years of age. Because of the rarity of thymomas, lack of uniformity in treatment has been a major problem over the years. Therefore, international collaborations have been established, and national oncological centralisation of management has been arranged in order to improve the treatment and prognosis.
authors.affiliation: Onkologisk Klinik, Rigshospitalet, Denmark.
authors.forename: Julie
authors.initials: J
authors.lastname: Abildgaard
authors.forename: Helle
authors.initials: H
authors.lastname: Pappot
authors.forename: Peter Meidahl
authors.initials: PM
authors.lastname: Petersen
authors.forename: Mikael
authors.initials: M
authors.lastname: Rørth
authors.forename: Jesper Holst
authors.initials: JH
authors.lastname: Pedersen
authors.forename: Eric
authors.initials: E
authors.lastname: Santoni-Rugiu
authors.forename: Gedske
authors.initials: G
authors.lastname: Daugaard
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000150:complications; D003131:Combined Modality Therapy; D006801:Humans; D009367:Neoplasm Staging; D015996:Survival Rate; D013945:Thymoma / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D013953:Thymus Neoplasms / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents